Stay up to date with our latest news and events.
Proteos would like to wish you a very Happy Thanksgiving!
Proteos, along with our pets, wish you a happy and safe Halloween!
There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens. These variables include construct design, affinity tags, expression system, purification scheme, formulation, and characterization. Here we will focus on methods for determining protein quality.
There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens. These variables include construct design, affinity tags, expression system, purification scheme, formulation, and characterization. Here we will focus on considerations for long-term storage of recombinant antigens.
Partner with Proteos, a proud US-based service company, to advance your discovery research program. Contact us today to start the conversation. Wishing you a safe and enjoyable holiday!
There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens. Here we will focus on the use of affinity tags in recombinant antigen production.
There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens. These variables include construct design, affinity tags, expression system, purification scheme, formulation, and characterization. Here we will focus on selecting an appropriate expression system for recombinant antigen production.
In celebration of Arbor Day, let us all consider how we can contribute to conservation of our environment, for present and for future generations.
There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens. These variables include expression system, purification techniques, protein tags, formulation, and assessment.
Proteos is an industry leader in the production of high-quality recombinant antibodies for drug discovery research. Here we will focus on the benefits of producing mAbs recombinantly in mammalian cells.
